000 03966cam a2200721Ii 4500
001 ocn858861712
003 OCoLC
005 20171106083115.0
006 m o d
007 cr cnu---unuuu
008 130924s2013 nju ob 001 0 eng d
020 _a9781118660379 (ePDF)
020 _a1118660374 (ePDF)
020 _z9781118179796
020 _z111817979X
020 _a9781118659984 (epub)
020 _a1118659988 (epub)
020 _a9781118660409 (emobi)
020 _a1118660404 (emobi)
020 _a9781118660485
020 _a111866048X
029 1 _aAU@
_b000052334807
029 1 _aNZ1
_b15340181
029 1 _aDEBBG
_bBV041572424
029 1 _aNLGGC
_b369354931
029 1 _aAU@
_b000052749422
029 1 _aDEBBG
_bBV043396228
035 _a(OCoLC)858861712
_z(OCoLC)862828741
_z(OCoLC)961559519
_z(OCoLC)962711076
040 _aN$T
_beng
_erda
_epn
_cN$T
_dE7B
_dCUS
_dWAU
_dCDX
_dCOO
_dNLGGC
_dYDXCP
_dEBLCP
_dK6U
_dOCLCF
_dDEBBG
049 _aMAIN
050 4 _aRS380
060 1 4 _aQV 35
072 7 _aMED
_x071000
_2bisacsh
082 0 4 _a615/.19
_223
100 1 _aHo, Rodney J. Y.
245 1 0 _aBiotechnology and biopharmaceuticals : transforming proteins and genes into drugs /
_cRodney J.Y. Ho and Milo Gibaldi.
_h[electronic resource]
250 _aSecond edition.
264 1 _aHoboken, New Jersey :
_bWiley Blackwell,
_c[2013]
264 4 _c©2013
300 _a1 online resource (xxvi, 698 pages)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
504 _aIncludes bibliographical references and index.
505 0 _aIntroduction to biopharmaceuticals -- Distinctions of biologic versus small molecule platforms in drug development -- Financing biologic drug development -- Application of biotechnology in drug discovery and early development -- Large-scale production of recombinant proteins -- Clinical pharmacology, toxicology, and therapeutic dosage & response -- Clinical evaluation and regulatory approval & enforcement of biopharmaceuticals -- Pharmacoeconomics and drug pricing / Garrison -- Antibodies and derivatives -- Hematopoietic growth and coagulation factors -- Cytokines and interferons -- Hormones -- Enzymes -- Vaccines / Hu, Ho -- Other biopharmaceutical products -- Advances in personalized medicine : pharmacogenetics in drug therapy -- Gene and cell therapy -- Pharmacoeconomics, outcome, and health technology assessment research in drug development -- Summary and future prospects.
520 _aBiotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs, Second Edition addresses the pivotal issues relating to translational science, including preclinical and clinical drug development, regulatory science, pharmaco-economics and cost-effectiveness considerations. The new edition also provides an update on new proteins and genetic medicines, the translational and integrated sciences that continue to fuel the innovations in medicine, as well as the new areas of therapeutic development including cancer vaccines, stem cell therapeutics, and cell-based therapies.
588 _aDescription based on print version record.
650 0 _aPharmaceutical biotechnology.
650 7 _aMEDICAL / Pharmacology
_2bisacsh
650 2 _aBiopharmaceutics.
650 2 _aChemistry, Pharmaceutical.
650 2 _aDrug Design.
650 4 _aBiopharmaceutics.
650 4 _aChemistry, Pharmaceutical.
650 4 _aDrug design.
650 7 _aPharmaceutical biotechnology.
_2fast
_0(OCoLC)fst01060106
655 4 _aElectronic books.
655 0 _aElectronic books.
700 1 _aGibaldi, Milo.
776 0 8 _iPrint version:
_aHo, Rodney J. Y.
_tBiotechnology and biopharmaceuticals.
_bSecond edition
_z9781118179796
_w(DLC) 2013006645
_w(OCoLC)828334052
856 4 0 _uhttp://onlinelibrary.wiley.com/book/10.1002/9781118660485
_zWiley Online Library
942 _2ddc
_cBK
999 _c206995
_d206995